Literature DB >> 20678995

ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.

L Y Hu1, Z G Sun, Y M Wen, G Z Cheng, S L Wang, H B Zhao, X R Zhang.   

Abstract

The protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70 ribosomal S6 protein kinase (p70S6K) signaling pathway, as a central controller of cell growth, proliferation, survival, and differentiation in response to extracellular signals, growth factors, nutrient availability, energy status of the cell, and stress, has recently gained attention in neuroscience. The effects of this signaling pathway on repair of spinal cord injury (SCI), however, have not been well elucidated. ATP is increasingly recognized as an important regulator of signal transduction pathways, and plays important roles in functional recovery after nervous system injury. In the present study, we examined the ATP-induced changes of the Akt/mTOR/p70S6K signaling pathway in injured spinal cord of adult rats and potential therapeutic effects of this pathway on SCI-induced locomotor dysfunction. SCI was produced by extradural weight-drop using modified Allen's stall with damage energy of 50 g-cm force. The rats were divided into four groups: SCI plus ATP, SCI plus saline, SCI plus ATP and rapamycin, and sham-operated. Using immunostaining studies, Western blot analyses and real-time qualitative RT-PCR analyses, we demonstrated that the Akt/mTOR/p70S6K signaling pathway is present in the injured spinal cord and the expression of its components at the protein and mRNA levels is significantly elevated by exogenous administration of ATP following SCI. We observed the effectiveness of the activated Akt/mTOR/p70S6K signaling pathway in improving locomotor recovery, significantly increasing the expression of nestin, neuronal nuclei (NeuN), neuron specific enolase (NSE), and neurofilament 200 (NF200), and relatively inhibiting excessive reactive astrogliosis after SCI in a rapamycin-sensitive manner. We concluded that ATP injection produced a significant activation of the Akt/mTOR/p70S6K signaling pathway in the injured spinal cord and that enhancement of rapamycin-sensitive signaling produces beneficial effects on SCI-induced motor function defects and repair potential. We suggest that modulation of this protein kinase signaling pathway activity should be considered as a potential therapeutic strategy for SCI. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678995     DOI: 10.1016/j.neuroscience.2010.05.046

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  23 in total

1.  Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice.

Authors:  Juyeon Park; Jimmy Zhang; Jianhua Qiu; Xiaoxia Zhu; Alexei Degterev; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-21       Impact factor: 6.200

2.  Blocking Autophagy in Oligodendrocytes Limits Functional Recovery after Spinal Cord Injury.

Authors:  Sujata Saraswat Ohri; Andrew N Bankston; S Ashley Mullins; Yu Liu; Kariena R Andres; Jason E Beare; Russell M Howard; Darlene A Burke; Amberly S Riegler; Allison E Smith; Michal Hetman; Scott R Whittemore
Journal:  J Neurosci       Date:  2018-05-23       Impact factor: 6.167

3.  BDNF Overexpression Exhibited Bilateral Effect on Neural Behavior in SCT Mice Associated with AKT Signal Pathway.

Authors:  Mei-Rong Chen; Ping Dai; Shu-Fen Wang; Shu-Hua Song; Hang-Ping Wang; Ya Zhao; Ting-Hua Wang; Jia Liu
Journal:  Neurochem Res       Date:  2016-06-09       Impact factor: 3.996

Review 4.  PI3 Kinase regulation of neural regeneration and muscle hypertrophy after spinal cord injury.

Authors:  Tengfei Zhao; Yiying Qi; Yan Li; Kan Xu
Journal:  Mol Biol Rep       Date:  2011-07-01       Impact factor: 2.316

5.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

Review 6.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

7.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 8.  The role of mTOR signaling pathway in spinal cord injury.

Authors:  Haruo Kanno; Hiroshi Ozawa; Akira Sekiguchi; Seiji Yamaya; Satoshi Tateda; Kenichiro Yahata; Eiji Itoi
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

9.  Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.

Authors:  Neil E Kay; Traci Sassoon; Charla Secreto; Sutapa Sinha; Tait D Shanafelt; Asish K Ghosh; Jack L Arbiser
Journal:  Leuk Lymphoma       Date:  2016-05-17

Review 10.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.